Urology Awareness Month: Latest discussion and news See their Programe for their month of activities on different aspects and impacts of urological conditions that can impact on each and every family member at their different ages and stages of development and life cycle!
Slow down your natural ageing clock now!
Univ. of Virginia, School of Medicine researchers discovery – a key driver of chronic inflammation causing ageing to accelerate in human bodies. This finding can potentially lead to a position where we could slow down our natural ageing clock and so live longer,healthier lives, where many age related conditions like heart disease and devastating brain…
Can hearing aids really slow down Alzheimer’s disease?
A systematic review of literature on diabetes, its potential impacts on hearing loss, and a discussion of the clinical implications. By Emily Urry, PhD and Elizabeth Stewart, AuD, PhD Across a lifespan, an individual’s hearing capacity is influenced by genetic, biological, psychosocial, and environmental factors. These factors can either lead to hearing loss or protect…
Arterial hypertension – a leading cause of death
Arterial hypertension – a leading cause of death. Partly due to ageing, the rising incidence of obesity, and socio economic and environmental changes, its incidence increases worldwide. Hypertension commonly coexists with Type 2 diabetes, obesity, dyslipidaemia, sedentary lifestyle, and smoking leading to risk amplification. Blood pressure lowering by lifestyle modifications and anti hypertensive drugs reduce…
Gendered impacts of disease outbreaks.
Gendered impacts of disease outbreaks! Policies and public health efforts have not addressed the gendered impacts of disease outbreaks. The response to coronavirus disease 2019 (COVID-19) appears no different. We are not aware of any gender analysis of the outbreak by global health institutions or governments in affected countries or in preparedness phases. Recognising the…
Include women in Clinical Trials!
The EIWH was recently invited to provide content for a guest blog by the European Federation of Pharmaceutical Industries and Associations (EFPIA) The subject chosen by the EIWH was: “The inclusion of women in clinical trials.” You can read this article at the following link. Including Women in Clinical Trials
Vaccination reduces illness in children!
Vaccination reduces illness in children A recent study shows that the UK’s vaccination programme against group B meningococcal disease (MenB) has reduced cases of meningitis and septicaemia in young children by almost two-thirds. The UK was the first country to offer this new vaccine against MenB in 2015 and since then approximately 90% of infants…
Guide on biosimilars for healthcare professionals
EMA published the information guide on biosimilars for healthcare professionals in 15 additional EU languages. It now includes Bulgarian, Czech, Danish, Greek, Estonian, Finnish, Croatian, Hungarian, Lithuanian, Latvian, Maltese, Romanian, Slovak, Slovenian and Swedish. These educational materials on biosimilar, and link to the Q&A for patients, can be found on EMA’s webpage on biosimilar medicines…
Use in pregnancy and women of childbearing age of valproate
Review of valproate use in pregnancy and women of childbearing age EMA to consider risks of these medicines require further restrictions of use The European Medicines Agency (EMA) has started a review looking at the use of valproate containing medicines in the treatment of women and girls who are pregnant or of childbearing age. These…
Final guidance for treating neuroendocrine tumours (NETs)
Guidance issued by NICE (England) for treating neuroendocrine tumours (NETs) Final guidance recommending everolimus (Infinitor, Novartis) and sunitinib (Sutent, Pfizer) to treat neuroendocrine tumours (NETs). The drugs are recommended as an option for pancreatic NETs that cannot be operated on and have progressed. Everolimus is also recommended as an option for those with NETs of…